Week 10 Flashcards

(100 cards)

1
Q

how does the immune system achieve this

A

Danger signals (PAMPS,DAMPS)—> antigen presenting cells
—> instructions (pMHC, co-stimulatory mol, cytokines)
—> CD8 T cells (cytotoxic T lymphocytes), CD4 T cells (coordinate produce cytokines)
B cells <—>instructions (germinal centre reaction, CD40:CD40L, cytokines, co-stimulation)—> CD4 T cells
B cells produce antibodies
—> instructions (complement fixation, ADCC cytokines)
-complement C4 C3, neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cells and molecules in the immune system

A

B cells: differentiates into plasma cells producing antibodies, opsonisation, complement activation, toxin neutralisation
T cells: CD4 helper T cells provide B cells with signals necessary for antibody production. CD8 cytotoxic T cells destroy virally infected cells. T regulatory cells suppress auto-reactive T cells
phagocytes: engulf and destroy extracellular pathogens, clears cellular debris, antigen presentation
Complement: opsonisation C3b, immune complex clearance C1q, terminal components create the membrane attack complex
NK cells: destroys virally infected cells and tumour cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Immune deficiency

A

Exposure to pathogen
Virulence of pathogen
Immune competence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Immune deficiency timeline

A

Neonates (0-4wk) and infant (4-52wk): SCID,CID,severe neutropenia
Young children (1-4yrs): antibody deficiency XLA, complement deficiency, innate defects
Older children (4-16yrs): CVID, complement defects
Adults (16 years): CVID, secondary immunodeficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

When to think about immunodeficiency

A

Several recurrent or invasive infections
Unusual organisms or site of infection
Severe recurrent or disproportionate inflammation
Unexplained lymphoproliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Primary and secondary immunodeficiency

A

Primary: genetic (FMHx!!), rare (450 different PIDs), often early in life but CVID in adulthood
Secondary: acquired, common (30x more common than PID), increasing likelihood with age, treatment and comorbidities.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The four Rs of immune responses

A

Recognition
Response Infections dominate
Regulation
Resolution and memory. Immune dysregulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where could the defect be

A

Innate defects (neutrophils, complement)
Global defect (signalling, cytokines)
T cell (cellular) defect + combined defect+ B cell (humoral) defect
Non immune defects: eg anatomical/structural problems, neurological problems, biochemical problems
The age, anatomical site, infectious and immune dysregulatory features of the presentation provide clues on where the defect is

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What happens when they go wrong

A

B cells: can’t make antibodies. Recurrent bacterial sinopulmonary infections (encapsulated organisms). Chronic or recurrent gastroenteritis (enterovirus, giardia). Chronic enteroviral meningoencephalitis. Septic arthritis (strep, staph, mycoplasma, ureasplasma). Bronchiectasis
T cells: fungal infections (pneumocystis Jiroveci pneumonia). Several or unusual viral infections (EBV, CMV, adenovirus). Mycobacterial infection, failure to thrive, chronic diarrhoea, GVHD-like phenomenon (rash, abnormal LFTs), auto-immune disease
Phagocytes: skin abscesses or lymphadenitis, bacterial pneumonia, poor wound healing, delayed separation of the umbilical cord (LAD), chronic gingivitis, periodontal disease, mucosal ulcerations, disseminated NTM
Complement: recurrent neisserial infections, pyogenic bacterial infections, autoimmune disease (lupus), angioedema of face, hands, feet, GIT
NK cells: severe or recurrent herpes virus infections, HLH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Barrier problems (non-immune defect)

A

Kartagener’s syndrome: cilia defect leading to bronchiectasis
Cystic fibrosis: salt transfer defect results in sticky secretions
Ureteric reflux: inefficient flow
Eczema: filagrin defect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Neutrophils immunodeficiency

A

Primary immunodeficiency:
-congenital neutropenia
- leukocyte adhesion deficiency
-chronic granulomatous disease
Secondary immunodeficiency:
-cytotoxic chemotherapy
-BMT
-steroids
Neutrophils:
-immune first responders
-migrate to site of infection
-phagocytose and destroy pathogens
-form NETs to contain pathogens
-Make pus

Skin infections, abscesses, septicaemia, invasive fungal, infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Leukocyte adhesion deficiency

A

Beta-2 integrins - if not genetically deficient unable to tightly bind and enter tissue, presents early in childhood
Binds ICAM1 on cell surface so tight binding does not occur
No pus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Chronic granulomatous disease

A

Staphylococcus
Aspergillus
Nocardia
Serratia
Klebsiella
BCGosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Neutropenia (congenital/acquired)

A

Neutropenic sepsis
Acquired more common, when given cytotoxic chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Complement immunodeficiency

A

Classical pathway: C1q, C2, C4– lupus like disease. Can’t clear apoptotic cells or activate Ab-C immunity
MBL deficiency (usually asymptomatic, may be a risk factor for recurrent infn)
Alternative pathway (factor B&D- Neiserria meningitis, factor I and H- aHUS)
-C3
—C5
TCC-(C5b-C9) Neiserria meningitis. Can’t punch holes in membranes of pathogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Signalling problems

A

Immune cell signalling is very complex
It’s is relevant to disease and therapeutics
Monogenic defects in signalling pathways give characteristic disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Mendellian susceptibility to mycobacterial infection (MSMD-IFNg receptor defect most common cause)

A

Naive T cell:
-Th1 T cell -> IFNg (acts on mono/mac). Th1:fights intracellular pathogens (eg MTB, NTM, salmonella)
-Th2 T cell-> IL-4. Th2: fights extracellular pathogens (eg worms, parasites)
-TH17 T cell-> IL-17. Th17: fights fungi (recruits neutrophils to mucosal surfaces)

Most commonly presents in children after BCG vaccination
Defect in interferon-gamma receptor. Prone to TB, salmonella
BCGosis lymph node spread of bacteria from vaccine strain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

B cell problems

A

Primary immunodeficiency:
-X-linked agammglobulinaemia
-autosomal recessive agammaglobulinaemia
-hyper IgM syndrome
-common variable immunodeficiency
Secondary immunodeficiency:
-B cell depletion
-BMT
-lymphoma/leukaemia treatment

B cells:
-produce antibody
-professional APC
-CSR and AFM
-produce memory B cells
-produce plasma cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

X-linked agammaglobulinaemia (BTK deficiency)

A

Mainly boys. 1st child diagnosed slower
BTK allows B cells to move in
Pro B—> pre B dependent on BTK. BTK allows the B cell receptor to signal to keep the developing B cell alive
If deficiency in BTK
No antibodies: babies born without ability to produce antibody. Protected first months-maternal antibodies. After they’re very prone to: pneumococcus, haemophilus, moraxella, enterovirus
Present with recurrent pneumonias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Hyper IgM syndrome (CD40L deficiency)

A

Defect in interaction between T and B cells to produce class switching
IgM can be produced (naive B cells) but high affinity IgG (memory B cells) not produced
Also a wider defect with myeloid lineages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Common variable immunodeficiency

A

Incidence 1/10000, highly variable age of onset + symptoms
Hypogammaglobulinaemia: low IgG and low IgA/IgM
-100% of patients.—> recurrent infections (sinopulmonary) Bronchiectasis
Polyclonal lymphoproliferation—> enlarged LN, spleen lymphoma risk
Autoimmunity—> ITP, AIHA, hypothyroid, alopecia, vitiligo
Granulomatous disease—> GL-ILD, GI granulomata
Enteropathies —> chronic norovirus, IBD, (NRH)
The genetics underlying CVID are being unraveled by genomic medicine techniques

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

IgA deficiency

A

1:400 prevalence
IgA is so important for mucosal immunity but the fact individuals usually entirely well suggests there is compensation/redundancy
Usually an incidental finding
Sometimes associated with IgG2 subclass deficiency and infections and autoimmunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Management of antibody deficiency

A

Antibody replacement (IVIG/SCIG)
Vaccines
Prophylactic antibiotics
Respiratory precautions
Early treatment of infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

T cell problems

A

Primary immunodeficiency:
-severe combined immunodeficiencies
-combined immunodeficiencies
-congenital athymia (eg 22q11 microdel)
Secondary immunodeficiency:
-T cell depleting therapy
-BMT
-immune suppression
-Acquired athymia
-HIV
T cells:
CD4+ coordinate immune responses
CD8+ destroy virally infected cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Severe combined immunodeficiency (X-linked SCID most common; Yc deficiency)
T cell precursor——> naive T cell Thymic T cell development T cell receptor produced Positive selection Negative selection
26
22q11 microdeletion syndrome Di George syndrome
C- cardiac abnormalities A- abnormal faces: small face, smooth philtrum, underdeveloped jaw, thin upper lip, small eye openings, low nasal bridge T-thymic aplasia/hypoplasia C-cleft palate H- hypocalcaemia 22-chromosomal abnormality
27
Consequence of improved treatments
SLE and systemic vasculitis: -10 year survival approximately 90% -infection 20-55% of deaths Dialysis: -yearly mortality 20% -infection 30% Rituximab (anti-CD20 treatment) -after 5 cycles 1/3 will have low immunoglobulins iatrogenic combined immunodeficiency
28
What are vaccines
Vaccines are artificial ways of introducing memory to a pathogen Memory normally develops during/after infection Memory is important for generating a faster, adaptive immune response Vaccines work before pathogen can proliferate and cause disease
29
Mechanism of action
Vaccines work through antibody High affinity class switched antibody. Not IgM, at end immune response Need antibody that targets epitopes or proteins that are protective
30
Producing that high affinity antibody
IgG antibody: as germinal centres develop Less IgM antibody
31
Vaccination also leaves us with more antigen specific cells (memory cells)
Immunised donor secondary response: -higher frequency of antigen-specific B cells than unimmunised donor primary response -IgG, IgA instead of IgM>IgG Affinity of antibody higher Somatic hypermutation higher
32
Vaccine efficacy
Vaccination is the single most cost effective health care intervention Huge impact on childhood morbidity and mortality
33
The ideal vaccine
Safe: must not cause illness and death Protective: efficacy must be high Sustained protection: protection should last several years Induce neutralising antibody : some pathogens infect cells that cannot be replaced so need neutralising antibodies to prevent such infection (polio/neurones) Practical: low cost, stable, easy to administer, no side effects
34
Passive V active immunity
Passive: donating immunity Active: activating the host to develop immunity
35
Passive immunoprophylaxis
Giving someone antibodies: Human serum: -rabies -rhesus D -VZV Animal serum: -tetanus Monoclonal antibodies: -anti RSV- palivizumab -anti sars CoV2-regeneron Pros: immediate protection, no 2 week lag generating a germinal centre, specific antibody to disease Cons: short lasting, half life IgG 14-21 days
36
Active vaccination
Whole microorganism: -live attenuated (BCG, yellow fever, VZV, MMR) -dead (whole cell pertussis, rabies) Subunit of microorganism: -inactivated toxin (tetanus and diphtheria toxoid) -recombinant proteins (hepatitis B, HPV) -polysaccharide (pneumococcus, meningococcus) -conjugate vaccines polysaccharide combined with more immunogenic conjugate to elicit T cell help -viral vector -mRNA
37
Live-attenuated
The pathogenic virus is isolated and grown in non-permissive cells to encourage mutations that attenuate growth in the original host You can also use different temperatures too In reality this process is very long More modern techniques would involve genetically altering your pathogens to remove virulence Eg: BCG (for TB) Oral polio vaccine Measles
38
Inactivated
Virus is inactivated with UV, chemicals or heat and then injected Eg inactivated polio vaccine (IPV), influenza, pertussis (whopping cough) Eg virus inactivated with formalin,virus cannot infect/replicate in cells UV and chemicals (eg formalin, phenol, B-propiolactone) are more commonly used that heat because heat often destroys surface exposed antigens, reducing immunogenicity Sinopharm and sinovac both created inactivated SARS-COV-2 vaccines
39
“Modern” vaccines
Recombinant DNA technology has resulted in the development of new vaccine technologies Benefits: -eliminate risk of infection -can be mass produced -easily and quickly attenuated -can be quickly engineered to account for evolution of viruses -some are cheap and more stable Recombinant protein production- Hepatitis B vaccine first licensed in 1986
40
Bacterial capsules
Outer capsule is made of polysaccharide (sugar). Immune system doesn’t recognise it so hard to phagocytose Hides surface molecules from immune system Poorly immunogenic T-independent antigen responses are important
41
Protecting against encapsulated bacteria
Encapsulated bacteria: -pneumococcus (streptococcus pneumoniae) -meningococcus (neisseria meningitidis) -haemophilus influenzae b Important cause of infections at the extremes of life: -pneumonia -bacteraemia -meningitis -otitis media Poor response in children under 2 years: -main burden of disease in this age group
42
problem with immune responses to T independent antigens
B cells like to respond to this capsule Which means a lack T cell help: -lack of affinity maturation in germinal centres -poor memory induction
43
How to get a T cell response to sugar
conjugate vaccines: T cell perspective: -conjugate polysaccharide to protein antigen -vaccine (containing polysaccharide and protein) internalised by antigen presenting cell -APC presents peptides to CD4+ T helper cell -T cell will have a normal T cell response B cells may respond to both antigens But they will all get help from the T cells responding to the protein which means GCs can form
44
Success of conjugate vaccines
Hib vaccine virtually eliminates risk of Hib meningitis in children Men ACWY conjugate vaccine against meningococcus serotype Cresponsible for cluster outbreaks of meningitis (uni students0 Preventative 13-valent conjugate vaccine against pneumococcus
45
Viral vector vaccines
Genes encoding surface proteins of pathogens can be inserted in safe viruses (eg vaccinia, adenovirus, canary pox) “Safe”= mild disease, normally some replication Immune response against virus and the inserted antigens “Oxford” develops vaccines using adenovirus viral vectors (most famously at start SARS-Cov 2 pandemic)
46
How adenovirus and mRNA vaccines work
Adenovirus enters the body. Virus produces spike protein this is designed to be a single cycle so no risk of adenovirus infection MRNA material enters host cell. Cell uses mRNA to make spike (no DNA integration) Harmless spike protein released and presented to the immune system Spike specific T cells and antibodies produced So no risk of vaccine associated infection in immunodeficiency Block subsequent infection by blocking viral entry to cell
47
Adjuvants
Problem: some proteins can also be poorly immunogenic Solutions: adjuvants -a substance that enhances the immunogenicity of substances mixed with it
48
Adjuvants mechanisms of action
1. Convert soluble antigens to particulate material -enhances uptake by APCs -provides a depot of slow release of antigen -example: —alum (aluminium hydroxide)- used in vaccines for man (not without controversy) 2. Create an inflammatory environment: -enhanced immunogenicity -leads to up-regulation of co-receptors and production of inflammatory cytokines- increases danger signals
49
Vaccine effectiveness
How good is a vaccine at preventing infection Some are better than others: eg tetanus and diphtheria Length of response varies- pertussis catch up in pregnancy Vaccination programmes most effective when majority of susceptible population vaccinated herd immunity
50
Monitoring the response to vaccination (using them in clinic)
Not all vaccines induce long lasting immunity- how long do you need it for Which vaccine, if any, best in at risk groups: -extreme old age -immunosuppression -immunodeficient (primary or secondary) Are boosters required If someone gets reinfected post vaccination is it a milder disease course On going safety data needed: eg VIIT (vaccine induced immune thrombocytopenia and thrombosis)
51
Herd immunity
Situation in which enough of a population is vaccinated against an infectious organism Factors affecting herd protection: -coverage rates -susceptibility of hosts -vaccine effectiveness -force of transmission -crowding -nasopharyngeal carriage Individual protection versus community protection: -who are the groups you cant reach -or who cant reach you
52
Many challenges remain
Vaccines are not effective in all people Often those in greatest need receive the least benefit (the young, the elderly and those with co-morbidities) Dealing with social concerns is an on going issue Some disease are difficult to vaccinate against, either because of constant mutation (eg flu) or because of difficulties in identifying protective epitopes (HIV) As Ebola/SARS-CoV-2/monkey pox demonstrates new threats can appear rapidly
53
Egg allergy and flu vaccine
Flu vaccine developed in eggs Small ovalbumin content in flu vaccine Risk of anaphylaxis in a egg allergic patient
54
Porcine products in some vaccines
In the UK routine immunisation programme there are 3 vaccines that contain porcine gelatine: -Fluenz, Tetra, the nasal spray vaccine that protects children against flu. No alternative childhood spray MMR VaxPro, a vaccine that protects against measles, mumps and rubella. Priorix does not contain gelatine and is as safe and effective Zostavax the vaccine that protects older adults against shingles no alternative in the UK In the clinic order in Priorix and listen to patients concerns can’t assume anything as things are complicated
55
Live vaccines
Patients on immunosuppression or who are immunosuppressed are at risk of developing the disease contained within the live vaccine Yellow fever in travel clinics Also MMR given at 1 year (BCG now given selectively) VZV for shingles and chicken pox
56
Joint committee of vaccination and immunisation (JCVI)
The group of experts that devise UK vaccination programmes: -consider the pros and cons of particular vaccinations -public health needs -cost effectiveness E.g how much disease do you have to prevent to allow a certain cost or risk of side effect Green book has the latest information on vaccines and vaccination procedures for vaccine preventable infectious diseases in the UK
57
Viruses and cancer
Viruses are pathogenic in a number of cancers Human papilloma viruses - cervical, genital and oesophageal cancer Epstein Barr virus- B cell lymphoma, nasopharyngeal cancer HBV and HCV- hepatic cancer Human herpes virus 8- Kaposi’s sarcoma Human T lymphotropic virus 1 (HTLV1)- adult T cell lymphoma/leukaemia
58
Successful cancer vaccines
Prevention: HPV and cervical cancer Research aims to provide remission/cure: -either alerts or enhances the immune response against cancer cells -introduce viral vectors that can manipulate DNA in cancer cells
59
Controversy in vaccination
Disproportionate fear of side effects Vaccine side effects do occur and there is a vaccine fund set up by the government to acknowledge this Individual vs the general population Misinformation feeding these fears -MMR and Andrew Wakefield -SARS-CoV-2 and various themes
60
The precarious balance of the early immune system
By birth: developed enough to fight infection In utero: suppressed enough to prevent rejection
61
Pregnancy loss
70% of conceptions do not survive Immunological causes: -autoantibodies —SLE —thyroid disease -NK cell abnormalities -anticardiolipin antibodies -mostly we don’t know
62
How does the foetus escape the maternal immune system
The mother and the placentas responsiveness to threat is diminished Maternal immunity down regulated -increase in regulatory T cells -reduced CD8 and NK cell cytotoxic responses Repressed paternal HLA class II in trophoblasts Placental tolerance: -synthesis of immunosuppressive molecules by the placenta —progesterone, PGE2, anti-inflammatory cytokines IL-10 and IL-4, complement regulatory proteins -down regulated expression of HLA class I in placenta -T cell costimulation down regulated -enhanced killing of immune activated cells
63
Maternal tolerance and immune suppression
Associated with increased risk of infection Balance between tolerance and protection
64
Maternal antibody transfer
IgG antibodies cross the placenta in the last trimester of pregnancy Protects the baby in the first 6 months of life whilst adaptive response under-developed Assuming baby is born at term, if premature baby might not have had IgG transfer increasing risk of infection When mother has autoimmune antibody: -can transfer onto foetus. Transient autoimmunity whilst maternal IgG wanes. Neonatal lupus etc
65
Neonatal lupus
Antibodies can cause short term problems: -hepatitis -thrombocytopenia Antibodies can cause long term problems: -Eg RO antibodies attack myocardial conducting system causing congenital heart block so can’t get conduction of electrical waves. Permanent cardiac problems
66
rhesus incompatibility- blood group antigens
Rh +ve father with Rh-ve mother when baby is Rh+ve 1st pregnancy- mum produces antibodies against babies Rh +ve antigens (inherited from dad) in 3rd trimester when get transplacental maternal foetal mixing. So mother starts producing immune response but isn’t much of a problem in first pregancy 2nd pregnancy when baby Rh+ve mother has preformed antibodies against baby red cells which attack baby red cells. Baby severely anaemic, splenomegaly, hepatomegaly, fatal If mum is Rh+ve not a problem
67
Haemolytic disease of the foetus and newborn
Anaemia commonly occurs in the baby because baby’s red cells are being destroyed by mums antibodies (type II hypersensitivity reaction) Mum is fine About 50% babies have mild disease Rare severe manifestation of this is hydrops Fetalis where fluid builds up in baby’s tissues and organs
68
Immune protection in the newborn
Passively acquired maternal antibodies: -these antibodies are protective -trans placental in last trimester -protect for approximately 6 months Breast feeding: -anti microbial, anti inflammatory, immune modulators -most effective preventative measure for reducing the death rate for children under 5: —breast feeding > 6months may prevent 13% of early life deaths -reduced RSV infection, pneumonia, otitis media and GI infections Neonatal immune system: -vaccination
69
Leading causes of death in children under 5
Preterm birth complications Pneumonia Intrapartum events Diarrhoea Neonatal sepsis Malaria Significant number of deaths to infection
70
Why is the infant susceptible to infection
Immune factors: -cells missing?(not really lymphocytes and neutrophil counts very high at birth) -immune functions are immature- suppressed in utero not yet developed Structural: -small airways Environmental factors: -clean water for bottle milk -lack of social distancing
71
The neonatal immune system
Both innate and adaptive immune systems developed at birth but not as functionally efficient Newborns at higher risk of bacterial infections -often low virulence organisms: staphylococcus, pseudomonas These deficits are more striking in preterm infants
72
Low functional immune system
Small airways Sterile flora at birth- develops early in life Opsonic activity and complement reduced (C3 65% of adult levels) Phagocyte function reduced: opsonisation, reduced integrin and selectin Reduced monocyte motility Reduced antigen presenting cell function Adaptive immune response to protein antigens near normal -less to glycoproteins (improved by 6-9 months) -polysaccharides (improved by 1 year) B cells poorly active Higher numbers but poor function of lymphocyte and NK cells -lower levels of cytokines (IL-2, IL-4, IL-5, IL-12 and IFN-g)
73
The developing microbiome
Essential to immune and metabolic health Gut bacteria stimulate gut lymphoid tissue -protect against pathogens -influence oral tolerance and immune memory Precise implications on foetal and/or neonatal health still unclear -initial microbial exposure defines early life gut microbiome Can we manipulate developing gut microbiome and predisposition to disease
74
The ageing immune system
Increased infections with age -more opportunistic infections -reactivation of latent infections Increased autoimmunity Increased cancer
75
The ageing population
Impact on acute care Impact on social care Impact on economics and tax returns By 2034: 23% pop >65. 5% pop>85 years
76
Immunosenescence
“Remodelling and decline of the immune system” Higher risk of acute viral and bacterial infections Mortality rates from infection are 3x higher in elderly compared with younger adult patients Infectious diseases are still the 4th most common cause of death among the elderly in the developed world During a regular influenza season about 90% of the excess deaths occur in people aged over 65 Poor immune responses account for diminished efficacy of vaccines
77
Ageing and the immune system
Detect and kill pathogens -reduced - more severe infection Immune memory -reduced- recurrent infection Kill or remove damaged or transformed cells -reduced- more cancer and autoimmunity Differentiate between self and not self -reduced - collateral damage Thymus atrophies with age and mainly not functioning tissue 35 decline in thymic output per year in humans
78
T cell ageing
T cell production and education reduced T cell function altered More T cells focused on controlling latent infections like CMV Reappearance of latent viral infections. Existing immunity is waning Incidence of shingles increases with age Reduced vaccination efficacy and longevity: -decline in tetanus antibody levels over time accelerates with age
79
Lymphocytes cannot proliferate forever
Protect coding DNA from degradation and confer stability to the chromosome Telomere (DNA and protein) Loss of telomeres beyond a critical point leads to growth arrest
80
Autoantibodies and autoimmune disease increase with age
Reduction in tolerance mechanisms Rheumatoid factor and rheumatoid arthritis increases with age
81
T regulatory function declines with age
Reduced peripheral tolerance capability This and other multiple reasons why
82
Inflammageing
Aberrant immune responses can exacerbate inflammation -cardiovascular disease, stroke, Alzheimer’s disease Increased TFNa, IL-6, CRP, decreased IL-10 —> asymptomatic infections, macrophages, increased adiposity, senescent cells, reduced sex hormones Immune dysregulation rather than immunodeficiency
83
Autoimmunity= failure of self tolerance
Tissue specific vs systemic ~3% population affected up to 10% lifetime risk General features: -B cell and T cell reactivity to self antigens -frequently autoantibodies produced Partial heredity Genetic predisposition Environmental triggers. ———— multi step model pathogenesis
84
Why do we need to maintain tolerance
Vast repertoire of antigen specific receptors carried by effector (T &B) cells, formed in an unbiased way
85
How do we maintain tolerance
T cell tolerance; Central: -thymic positive selection -thymic negative selection Peripheral: -ignorance (privilege) -anergy -cell death ———— (no costimulation) -suppression (T reg cells ) B cell tolerance: Central: -early antigen encounter -pre lymphoid tissue -deletion or anergy Peripheral: -lack of T cell help
86
Loss of ignorance (mechanism of loss of tolerance)
Sympathetic ophthalmia is a condition where you have a penetrating injury to eye and an immune response occurs The penetrating injury results in elements of infra-orbital structures eg retina (privileged areas of eye) being released and becoming known to immune system Then on contralateral side (no injury) you get a similar immune response in that eye Results in destruction of retina
87
Mechanism of loss of tolerance cell death and anergy
Presentation of a self antigen and no other costimualtory signals between T cell and APC then T cell undergoes apoptosis or anergy Presentation of self antigen with danger signal providing co-stimulation eg infection. Bystander activation
88
Mechanisms of loss of tolerance suppression.
Loss of Treg function in RA transcription factor associated with Treg is Foxp3 Lots of Tregs in healthy people and individuals with RA Healthy Tregs express lots CTLA-4 however in RA Tregs don’t produced CTLA-4 which results in them losing their function
89
Summary of loss of tolerance
Most peripheral immune tolerance occurs at the level of the T helper cell and so does some cancer immune evasion Diseases may occur when there’s a breakdown in the mechanisms which prevent the activation of Thelper cells Loss of T cell tolerance has consequences: production of autoantibodies
90
Autoimmunity
Complement dependent lysis- paroxysmal cold haematuria Opsonisation- most haemolytic anaemias Immune complexes- serum sickness, SLE Receptor blockade- myasthenia, pernicious anaemia Receptor stimulation- Graves’ disease
91
Autoantibodies cause and/or effect
Antibodies to erythrocytes- cause haemolytic anaemia Antibodies to acetyl choline receptor cause myasthenia gravis Antibodies to heart muscle are secondary to myocardial infarction and do nothing Antibodies to everything are secondary to the core pathology in SLE but highly pathogenic
92
Tissue specific autoimmunity
Thyroid: graves, hashimotos Kidney/lung: goodpastures syndrome Pancreas: diabetes mellitus Parietal cells/intrinsic factor: pernicious anaemia Adrenal: Addison’s disease Acetylcholine receptor: myasthenia gravis
93
Tissue specific hashimotos
Weight gain, constipation, fatigue, hair thinning, vague joint pains, neck swelling, hoarse voice Hashimotos: hypothyroidism, autoantibodies and cells destroy thyroid Antibodies against: TSH receptor, thyroid peroxidase, thyroglobulin Blocks TSH binding and function, induces tissue destruction
94
tissue specific Graves
Weight loss, irregular heart beat, change in bowel habit (diarrhoea), hand tremor, anxiety, 2 months eye prominence, sore,dry eyes Hyperthyroidism Antibodies stimulate thyroid Cell division and thyroxine release Antibodies against thyroid antigens also stimulate; -orbital fat cells -muscle cells -fibroblasts
95
Tissue specific Goodpasture’s syndrome
4 weeks: fatigue, nausea, increasing pallor 2 weeks: cough, SOB, haemoptysis, bloody urine, peripheral oedema, oliguria Admitted to ITU: ventilation and dialysis Specific antibodies to the capillary basement membrane of glomerulus and lung alveoli Bleeding into lungs
96
Systemic autoimmunity
Rheumatoid arthritis affects: joints, nerve, skin, eye , lung, vasculature Systemic lupus erythematosus: affects potentially everything, most frequently: joints, skin, CNS, kidney, vasculature Scleroderma: affects: skin, lung, vasculature,kidney, joint, GIT
97
Rheumatoid arthritis
Sudden onset in hands, very stiff (2 hours), swollen,warm, tender joints Joints in hands, wrists, shoulders, feet and knees symmetrically A common chronic inflammatory joint condition 1% UK 600000 people Direct NHS costs £560m indirect £1.8bn Multifactorial aetiology Associated in some patients with autoantibodies Variable course with exacerbations and remissions Inflammation leads to joint damage (erosions) Can result in severe disability
98
RA is a systemic disease
Nodules Eye inflammation Lung fibrosis Vasculitis= blood vessel inflammation
99
RA is associated with autoantibody production
In some but not all patients Rheumatoid factor: antibodies to Fc of IgG -Present in 60% RA -associated with severe, erosive disease in RA -prevalence increases with age 20% of >60s -non specific -not a diagnosis test for RA Anti-CCP (cyclic citrullinated peptide): -antibodies to modified proteins found in the joint and elsewhere -strongly associated with smoking in RA -present in 60% RA -associated with severe erosive disease -more specific than RhF-less false positives
100
Autoimmune disease is often associated with genetic predisposition
HLA associations are interesting because HLA genes code for MHC proteins which presents antigen HLA genes also happen to be some of the most studied genes Non-biased methods of gene discovery have found strong associations in other genes Gene-environment interaction: Smoking causes high levels of citrullination in the lung